News Article

Obesity treatment and the rise of the GLP-1 agonist

17 August 2023

Candesic partner Dr Michelle Tempest and Dr Bharadwaj Chada feature on the new HealthcareMarkets UK issue. Our team investigates the rising trend of weight loss drugs, its implications, and how they work together with a growing offer of personalised weight management tools. With a prediction of more than half of the world`s population to be overweight or obese by 2035, these new tools are of critical importance. The topic gathered great attention recently. Here is some of the recent coverage:

→ Weight-loss drug heart benefit ‘significant’ – BBC News
→ Weight-loss drugs: will health systems and insurers pay for ‘skinny jabs’? | Financial Times (
→ NHS to offer weight-loss jabs via apps that help patients with obesity | Obesity | The Guardian (
→ Chinese drugmakers develop copycat versions of ‘miracle’ weight-loss drug | Financial Times (
→ A shot of reality – ScienceDirect